GO
Loading...

Enter multiple symbols separated by commas

Health Care Equipment

More

  • Boston Scientific posts loss on litigation costs Tuesday, 28 Apr 2015 | 7:22 AM ET

    April 28- Medical device maker Boston Scientific Corp reported a quarterly net loss due to one-time charges, including litigation costs of $193 million. The company reported a net loss of $1 million for the first quarter ended March 31, compared with a profit of $133 million a year earlier. Excluding charges, the company earned 21 cents per share.

  • April 27- Medtronic Plc has agreed to stop manufacturing and distributing its SynchroMed implantable drug pump, U.S. regulators said on Monday, a step toward resolving allegations that the company violated quality standards with the device which delivers pain medication to cancer patients and others. Medtronic failed to correct problems that could lead to...

  • April 27- Medtronic Plc has agreed to resolve U.S. regulators' allegations it violated quality standards for making its SynchroMed implantable infusion pump, which delivers medications to cancer patients and others with chronic pain. The agreement includes Medtronic Chief Executive Omar Ishrak and Senior Vice President Thomas Tefft.

  • April 27- Medical device maker Medtronic Plc said it reached a settlement agreement with the U.S. Food and Drug Administration over one of the company's drug delivery systems. The consent decree places some restrictions on the company and outlines the steps it must take to address the FDA's expectations, the company said on Monday. The agreement does not...

  • One start-up's quest to prevent breast cancer Tuesday, 21 Apr 2015 | 10:31 AM ET
    Mary-Claire King, the University of Washington geneticist whose work led to the discovery of the BRCA1 gene

    Color Genomics plans to charge only $249 for an analysis of cancer-risk genes. New York Times reports.

  • Hand us your data, we'll cut your rates: Hancock Sunday, 19 Apr 2015 | 11:00 AM ET
    The Fitbit Flex

    John Hancock aims to use wearables to track policyholders' activity, using the information to provide differential pricing on insurance policies.

  • UPDATE 1-FDA approves AcuFocus' corneal implant Friday, 17 Apr 2015 | 6:37 PM ET

    April 17- The U.S. Food and Drug Administration approved AcuFocus Inc's corneal implant to improve vision in patients with presbyopia, an age-related eye disorder. The device, KAMRA inlay, is the first implantable device to correct vision in patients who have not had cataract surgery, the FDA said in a statement on Friday. The FDA, however, warned that the device...

  • FDA approves AcuFocus' corneal implant Friday, 17 Apr 2015 | 5:49 PM ET

    April 17- The U.S. Food and Drug Administration approved AcuFocus Inc's corneal implant to improve vision in patients with presbyopia, an age-related eye disorder. The device, KAMRA inlay, is the first implantable device to correct vision in patients who have not had cataract surgery, the FDA said in a statement on Friday. Presbyopia is a condition associated...

  • NEW YORK, April 12- Medical researchers call it the "Angelina Effect," the surge in demand for genetic testing attributable to movie star Angelina Jolie's public crusade for more aggressive detection of hereditary breast and ovarian cancer. But there's a catch: Major insurance companies including Aetna, Anthem and Cigna are declining to pay for the latest...

  • April 1- NuVasive Inc said Chief Executive Office Alex Lukianov resigned after an independent investigation showed he had not complied with the medical device maker's expense reimbursement and personnel policies. The company said the amounts involved were not material to financial results. NuVasive also appointed board member Greg Lucier as interim CEO.

  • March 24- Merck& Co Inc said on Tuesday that it would stop a large study of its Keytruda melanoma treatment early because an independent monitoring committee determined the drug succeeded in its goal of prolonging survival in previously untreated patients at advanced stage of the disease. The medicine, a PD-1 inhibitor that works by taking the brakes off the...

  • March 16- A minimally invasive procedure that allows doctors to implant a new heart valve supplying blood to the body is safe for low-risk patients, according to a study presented at the American College of Cardiology meeting in San Diego. Samir Kapadia, a cardiologist at the Cleveland Clinic in Ohio. The results presented Sunday are of particular interest for...

  • The FDA action followed reports last month that hundreds of patients may have been exposed to pathogens, including antibiotic-resistant "superbugs," after flexible tubes called duodenoscopes were not properly disinfected between patients. The recommendations are based on draft proposals the FDA released for public comment in 2011 but never put into...

  • SEATTLE, March 5- A Washington state woman has filed a lawsuit against a hospital and a leading medical-device manufacturer claiming her husband died from a drug-resistant "superbug" he contracted from a contaminated medical scope, her lawyer said on Thursday. Theresa Bigler, of Woodway, is seeking unspecified monetary damages for the death of her husband...

  • The scopes were linked to the exposure of 179 patients to drug-resistant bacteria at UCLA's Ronald Reagan Medical Center in Los Angeles and may have contributed to two deaths. In early 2014, following a superbug outbreak at a hospital in Illinois, the FDA asked Fujifilm Holdings Corp, Olympus Corp and Pentax, which make the devices, to submit their test results...

  • *Cyberonics will have 54 pct of new group; Sorin 46 pct. MILAN, Feb 26- Italian medical device maker Sorin and its smaller U.S. peer Cyberonics Inc announced a merger on Thursday to create a global leader in cardiac surgery and neuromodulation with an equity value of $2.7 billion. Sorin's boss Andre-Michel Ballester will become chief executive and the board will be...

  • MILAN, Feb 26- United States- based medical device maker Cyberonics Inc has agreed to buy Sorin SpA in an all-stock deal that the Italian company said values it at about $1.4 billion. Cyberonics will hold a 54 percent stake in the new company and Sorin the rest. Cyberonics shareholders will receive one share of the new company for every share held, while Sorin...

  • Feb 17- Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson& Johnson to settle a long-running lawsuit over Boston Scientific's 2005 acquisition of rival Guidant. J&J had sought more than $7 billion in damages after it lost a bidding war to Boston Scientific following an initial deal to buy Guidant for $21.5...

  • Feb 17- Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson& Johnson to settle a long-running breach of merger lawsuit over Boston Scientific's 2005 acquisition of rival Guidant. J&J, which agreed to permanently dismiss its action without acknowledgment of liability by Guidant, had sought more than $7...

  • Feb 17- Medical device maker Medtronic Plc reported a better-than-expected quarterly profit, helped mainly by increased sales in its cardiac and vascular business, its largest. With sales of $2.22 billion in the third quarter ended Jan. 23, the business accounted for a little over half of overall sales. The company, which completed its acquisition of Ireland-...